Internal Medicine · Port Jefferson, NY
NPI
1619940269
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
710 Main St
Port Jefferson, NY, 11777
Phone (631) 474-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$260K
4,310 services
Medicare patients, 2024
615
Average age 79
Drug cost, 2024
$447K
5,952 prescriptions
Company payments, 2024
$32.67
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark J Dibenedetto was code 99214 (office e&m - established), 933 times for 542 patients. In total Mark J Dibenedetto billed 4,310 services in 36 codes, and Medicare paid $260K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 933 | 542 | $94.93 | $89K |
| 99213 Office E&M - Established | Office | 695 | 383 | $67.46 | $47K |
| 93000 Electrocardiogram | Office | 502 | 457 | $11.00 | $5,523 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 405 | 405 | $19.54 | $7,913 |
| G0008 Administration of influenza virus vaccine | Office | 329 | 329 | $37.09 | $12K |
| 90653 Vaccine Product | Office | 327 | 327 | $81.57 | $27K |
| 99497 Care Management/Coordination | Office | 223 | 221 | $66.01 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 198 | 186 | $12.40 | $2,456 |
| 99212 Office E&M - Established | Office | 142 | 117 | $42.16 | $5,987 |
| 99441 Telephone Services | Office | 109 | 88 | $44.64 | $4,866 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 75 | 65 | $165.82 | $12K |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 54 | 41 | $224.39 | $12K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 53 | 53 | $132.39 | $7,017 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 24 | 23 | $25.84 | $620 |
| 81002 Clinical Chemistry | Office | 20 | 16 | $3.41 | $68.2 |
By year: 2022 $383K for 5,014 services; 2023 $369K for 4,845 services; 2024 $260K for 4,310 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 20 | 16 | $3.41 | $68.2 |
| 82270 Immunoassay | 18 | 18 | $4.29 | $77.22 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark J Dibenedetto prescribed most often to Medicare patients was Losartan Potassium, with 506 prescriptions and refills. In total Mark J Dibenedetto wrote 5,952 Medicare prescriptions that cost $447K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 506 | 1,387 | 140 | $5,402 |
| Amlodipine Besylate Generic | 338 | 910 | 97 | $2,697 |
| Simvastatin Generic | 327 | 893 | 88 | $2,768 |
| Metoprolol Succinate Generic | 327 | 880 | 96 | $5,811 |
| Levothyroxine Sodium Generic | 305 | 772 | 65 | $4,272 |
| Atorvastatin Calcium Generic | 231 | 661 | 70 | $3,092 |
| Hydrochlorothiazide Generic | 205 | 511 | 56 | $1,218 |
| Rosuvastatin Calcium Generic | 179 | 491 | 54 | $3,686 |
| Hydralazine Hcl Generic | 145 | 277 | 28 | $2,966 |
| Ezetimibe Generic | 128 | 326 | 33 | $5,191 |
| Omeprazole Generic | 128 | 301 | 35 | $1,487 |
| Pantoprazole Sodium Generic | 125 | 269 | 42 | $1,570 |
| Eliquis Apixaban | 118 | 212 | 26 | $119K |
| Buspirone Hcl Generic | 117 | 234 | 31 | $1,060 |
| Synthroid Levothyroxine Sodium | 99 | 292 | 26 | $7,075 |
Brand drugs: - claims; generic drugs: 5,392 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark J Dibenedetto $32.67 ($32.67 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $32.67.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $32.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.